3D MEDICAL LTD 3D Medical Limited (ASX:3DM) (3D Medical or the Company) advises that Mr Max Ghobrial has retired from the role of Chief Executive Officer of the Company. Mr Ghobrial leaves 3D Medical well positioned and ready to launch aggressively into its next stage of growth and expansion. The Company takes this opportunity to extend its thanks to Mr Ghobrial for his efforts as inaugural CEO of 3D Medical.
As previously advised to the market, it is intended that upon completion of the proposed merger between 3D Medical and Mach7 Technologies Pte. Ltd (Mach7), the Company will change its name to Mach7 Technologies Limited, and restructure the Board and management team to better position the new Mach7 group of companies (Mach7 Group) to execute its strategy of global growth. As part of this restructure, it is expected that Mr Albert Liong, currently managing director of Mach7, will be invited to join the Board and appointed Managing Director of the Mach7 Group.
Mr Liong's appointment as Managing Director of the Mach7 Group will take place upon completion of the merger, which is currently expected to be in February 2016. In order to ensure business continuity in the interim, Dr Nigel Finch (Non-Executive Chairman) will assume an executive role at 3DM as Executive Chairman, effective 21 December 2015.
T: + 61 (0) 3 9286 7502
M: + 61 (0) 423 071 940
E: alyn.tai@3dmedical.com.au
About 3D Medical Limited:
At 3D Medical our aim is to aid medical professionals in the facilitation of improved clinical care, improving medical procedures, diagnostics and ultimately improving patient outcomes. 3D Medical is a medical specific 3D printing and holographic projection and data integrations provider. Our services 3D Medical Printing; EchoPixel (holographic projection technology); GestSure (in surgery image control); Mach7 (enterprise imaging solution provides healthcare organisations with the ability to archive, consolidate, access, and share medical imaging data across departments, locations and regions); and MediDATA provide medical practices the opportunity to leverage their analytical capabilities to gain an improved understanding of the characteristics of the patients which drive their business. These new and innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes. On 26 October 2015, 3D Medical announced that it had entered into a binding merger agreement with Mach7 Technologies. Subject to shareholder approval, and upon successful completion of the merger, 3D Medical will change its name to Mach7 Technologies.
About Mach7 Technologies:
Mach7 Technologies is a global provider of enterprise image management systems that allow healthcare enterprises to easily identify, connect, and share diagnostic image and patient care intelligence where and when needed. Mach7's award-winning platform delivers image management including rapid record identification, integration, synchronization and routing, advanced clinical viewing, and optimized vendor neutral archiving. Mach7 has locations in the U.S., Asia, Australia, and the Middle East. For more information, visit www.mach7t.com
3D Medical Limited ACN 007 817 192
Unit 4, 435 Williamstown Road, Port Melbourne, Victoria 3207
W:www.3Dmedical.com.au I E:info@3Dmedical.com.au I T:+613 9646 2222 I F:+613 9645 4707
3D Medical Limited issued this content on 2015-12-21 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-18 03:44:12 UTC
Original Document: http://3dmedical.com.au/wp-content/uploads/2016/01/3DM_ASX-Announcement_Senior-Management-and-proposed-Board-changes-lodged-21-December-2015.pdf
